̽»¨Ö±²¥

Intensive care unit (ICU) occupancy is likely to increase dramatically over the next few weeks, suggests research published by a team at the ̽»¨Ö±²¥ of Cambridge. Their work suggests that if the current exponential growth of COVID-19 infections continues, then within two weeks, five out of seven commissioning regions in England will have more critically ill COVID-19 patients than can be accommodated with ICU beds normally available. 

̽»¨Ö±²¥ ̽»¨Ö±²¥ of Cambridge is to take a leading role in a major national effort to help understand and control the new coronavirus infection (COVID-19) announced today by the Government and the UK’s Chief Scientific Adviser.

Researchers from the Cambridge Biomedical Campus have featured prominently in this year’s election to the prestigious European Molecular Biology Organisation (EMBO).

Scientists at the ̽»¨Ö±²¥ of Cambridge have developed a new test that can reliably predict the future course of inflammatory bowel disease in individuals, transforming treatments for patients and paving the way for a personalised approach.

A second person has experienced sustained remission from HIV-1 after ceasing treatment, according to a study published today in Nature.

'Beer before wine and you’ll feel fine; wine before beer and you’ll feel queer' goes the age-old aphorism. But scientists have now shown that it doesn’t matter how you order your drinks – if you drink too much, you’re still likely to be ill.

̽»¨Ö±²¥first major repository of legal practices for mediators and conflict parties to draw on when negotiating peace has won the top prize in this year’s Vice-Chancellor’s Impact Awards at the ̽»¨Ö±²¥ of Cambridge.

An algorithm to monitor the joints of patients with arthritis, which could change the way that the severity of the condition is assessed, has been developed by a team of engineers, physicians and radiologists led by the ̽»¨Ö±²¥ of Cambridge. 

Patients in intensive care units are at significant risk of potentially life-threatening secondary infections, including from antibiotic-resistant bacteria such as MRSA and C. difficile. Now, a new test could identify those at greatest risk – and speed up the development of new therapies to help at-risk patients.

Eight Cambridge academics are among 48 of the UK’s world leading researchers who have been elected to join the prestigious Fellowship of the Academy of Medical Sciences.